Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes
- 1 June 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 150 (3) , 239-246
- https://doi.org/10.1016/0014-2999(88)90004-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Long‐term imipramine treatment enhances locomotor and food intake suppressant effects of m‐chlorophenylpiperazine in ratsBritish Journal of Pharmacology, 1987
- Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeysLife Sciences, 1983
- Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazineEuropean Journal of Pharmacology, 1983
- Self-stimulation responses are altered following long-term but not short-term treatment with clorgylineBrain Research, 1983
- Changes in α- and β-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressantsNeuropharmacology, 1982
- (—)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodoneJournal of Pharmacy and Pharmacology, 1981
- Disposition and pharmacological effects of m-Chlorophenylpiperazine in ratsNeuropharmacology, 1981
- THE EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONOAMINE METABOLISM IN THE RAT BRAINJournal of Neurochemistry, 1979
- PLASMA LEVELS OF GROWTH HORMONE IN FEMALE RATS OF DIFFERENT AGESActa Endocrinologica, 1978
- Effects of pargyline on hypothalamic biogenic amines and serum prolactin, LH and TSH in male ratsLife Sciences, 1977